Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma. - Bahig, Houda; Aubin, Francine; Stagg, John; Gologan, Olguta; Ballivy, Olivier; Bissada, Eric; Nguyen-Tan, Felix-Phuc; Soulières, Denis; Guertin, Louis; Filion, Edith; Christopoulos, Apostolos; Lambert, Louise; et al. (BMC Cancer, 2019)